Literature DB >> 15090581

Treatment of anterior canal benign paroxysmal positional vertigo by a prolonged forced position procedure.

L Crevits1.   

Abstract

This report presents a therapeutic procedure for refractory benign paroxysmal positional vertigo (antBPPV) of the anterior canal. Two patients with refractory antBPPV were treated by a prolonged forced position procedure (PFPP). The technique is based on the assumption that the pathophysiological mechanism of antBPPV is similar to that generating posterior canal canalolithiasis. The patients recovered from refractory antBPPV after one or more PFPPs. The rationale for this therapy is that when the patient lies in the proposed forced position, the affected anterior canal is uppermost in an almost gravitationally vertical position. If the patient remains in this position for several hours, the floating particles lying in the non-ampullary arm of the canal can gradually slip out of the canal towards the vestibule due to gravity. We recommend trying PFPP when the side of lithiasis cannot be determined, in cases that are resistant to particle repositioning canal manoeuvres, and before considering canal plugging for refractory antBPPV.

Entities:  

Mesh:

Year:  2004        PMID: 15090581      PMCID: PMC1763591          DOI: 10.1136/jnnp.2003.025478

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  10 in total

Review 1.  [Benign paroxysmal positional vertigo].

Authors:  M von Brevern; T Lempert
Journal:  Nervenarzt       Date:  2004-09-11       Impact factor: 1.214

2.  Therapeutic efficacy of the Galletti-Contrino manoeuvre for benign paroxysmal positional vertigo of vertical semicircular canals in overweight subjects.

Authors:  Francesco Ciodaro; Valentina Katia Mannella; Rita Angela Nicita; Giovanni Cammaroto; Rocco Bruno; Bruno Galletti; Francesco Freni; Francesco Galletti
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-08-10       Impact factor: 2.503

3.  Natural course of positional down-beating nystagmus of peripheral origin.

Authors:  Jacopo Cambi; Serena Astore; Marco Mandalà; Franco Trabalzini; Daniele Nuti
Journal:  J Neurol       Date:  2013-01-05       Impact factor: 4.849

4.  Diagnostic Positional Tests and Therapeutic Maneuvers in the Management of Benign Paroxysmal Positional Vertigo.

Authors:  Swathi Vadlamani; Srinivas Dorasala; Sunil Narayan Dutt
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-01-02

5.  Benign paroxysmal positional vertigo.

Authors:  Seung-Han Lee; Ji Soo Kim
Journal:  J Clin Neurol       Date:  2010-06-30       Impact factor: 3.077

6.  New therapeutic maneuver for anterior canal benign paroxysmal positional vertigo.

Authors:  Dario A Yacovino; Timothy C Hain; Francisco Gualtieri
Journal:  J Neurol       Date:  2009-06-18       Impact factor: 4.849

7.  Repositioning maneuvers for benign paroxysmal positional vertigo.

Authors:  Daniel R Gold; Laura Morris; Amir Kheradmand; Michael C Schubert
Journal:  Curr Treat Options Neurol       Date:  2014-08       Impact factor: 3.598

8.  Diagnosis and Treatment of Anterior-Canal Benign Paroxysmal Positional Vertigo: A Systematic Review.

Authors:  Evangelos Anagnostou; Ioanna Kouzi; Konstantinos Spengos
Journal:  J Clin Neurol       Date:  2015-05-28       Impact factor: 3.077

9.  Anterior canal BPPV and apogeotropic posterior canal BPPV: two rare forms of vertical canalolithiasis.

Authors:  L Califano; F Salafia; S Mazzone; M G Melillo; M Califano
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-06       Impact factor: 2.124

10.  Feasibility of Using the Video-Head Impulse Test to Detect the Involved Canal in Benign Paroxysmal Positional Vertigo Presenting With Positional Downbeat Nystagmus.

Authors:  Andrea Castellucci; Pasquale Malara; Salvatore Martellucci; Cecilia Botti; Silvia Delmonte; Silvia Quaglieri; Elisabetta Rebecchi; Enrico Armato; Massimo Ralli; Marco Lucio Manfrin; Angelo Ghidini; Giacinto Asprella Libonati
Journal:  Front Neurol       Date:  2020-10-15       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.